Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial
Conroy, T., Castan, F., Etienne, P.-L., Rio, E., Mesgouez-Nebout, N., Evesque, L., Vendrely, V., Artignan, X., Bouché, O., Gargot, D., Boige, V., Bonichon-Lamichhane, N., Louvet, C., Morand, C., de la Fouchardière, C., Boilève, A., Delaye, M., Gourgou, S., Pezzella, V., Borg, C.
Published in Annals of oncology (01.10.2024)
Published in Annals of oncology (01.10.2024)
Get full text
Journal Article
PP 86 Immunohistochemistry and molecular biology of the PI3K pathway did not correlate with treatment efficacy of everolimus as second line or third line treatment of advanced endometrial carcinoma
Tredan, O, Pissaloux, D, Treilleux, I, Wanq, Q, Bonichon-Lamichhane, N, Mari, V, Freyer, G, Pujade-Lauraine, E, Ray-Coquard, I
Published in European journal of cancer (1990) (2011)
Published in European journal of cancer (1990) (2011)
Get full text
Journal Article
Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial
Kurtz, Jean-Emmanuel, Pujade-Lauraine, Eric, Oaknin, Ana, Belin, Lisa, Leitner, Katharina, Cibula, David, Denys, Hannelore, Rosengarten, Ora, Rodrigues, Manuel, de Gregorio, Nikolaus, Martinez García, Jeronimo, Petru, Edgar, Kocián, Roman, Vergote, Ignace, Pautier, Patricia, Schmalfeldt, Barbara, Gaba, Lydia, Polterauer, Stephan, Mouret Reynier, Marie-Ange, Sehouli, Jalid, Churruca, Cristina, Selle, Frédéric, Joly, Florence, D'Hondt, Véronique, Bultot-Boissier, Émilie, Lebreton, Coriolan, Lotz, Jean-Pierre, Largillier, Rémy, Heudel, Pierre-Etienne, Heitz, Florian
Published in Journal of clinical oncology (20.10.2023)
Published in Journal of clinical oncology (20.10.2023)
Get full text
Journal Article
712MO Final overall survival (OS) from the phase III ATALANTE/ENGOT-ov29 trial evaluating atezolizumab (Atz) versus placebo with standard chemotherapy (Cx) plus bevacizumab (bev) in ovarian cancer (OC) patients (pts) with platinum-sensitive relapse (PSR)
Kurtz, J.E., Pujade-Lauraine, E., Oaknin, A., Belin, L., Grimm, C., Kocian, R., Denys, H., Rosengarten, O.S., Follana, P., Sehouli, J., Martinez-Garcia, J., Alexandre, J., Hardy-Bessard, A-C., Frenel, J-S., Sabatier, R., Gladieff, L., De La Motte Rouge, T., Lamichhane, N. Bonichon, Kalbacher, E., Heitz, F.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1204MO PRODIGE 59 - DURIGAST trial: A randomised phase II study evaluating FOLFIRI plus durvalumab and FOLFIRI plus durvalumab plus tremelimumab in second-line treatment of patients with advanced gastric or gastro-oesophageal junction adenocarcinoma
Tougeron, D., Dahan, L., El Hajbi, F., Le Malicot, K., Evesque, L., Aparicio, T., Bouche, O., Bonichon Lamichhane, N., Chibaudel, B., Angelergues, A., A. bodere, Phelip, J.M., Mabro, M., Artru, P., Louvet, C.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
Adjuvant chemotherapy with or without atezolizumab for stage II and III triple-negative breast cancer: final analysis of the ALEXANDRA/ IMpassion030 phase 3 trial
McArthur, H., Bailey, A., Saji, S., El-Abed, S., Nader Marta, G., Metzger, O., Seiller, A., Shparyk, Y., Kim, H.J., Bonichon Lamichhane, N., Alonso, J.L., Ellingson, A., Zimina, A., Yamashita, T., Mohan, S., Shao, Z., Viale, G., Piccart, M., Ignatiadis, M., Gelber, R.
Published in European journal of cancer (1990) (01.03.2024)
Published in European journal of cancer (1990) (01.03.2024)
Get full text
Journal Article
304P ESR1 mutations and outcomes in BRCA1/2 or PALB2 germline mutation carriers receiving first line aromatase inhibitor + palbociclib (AI+P) for metastatic breast cancer (MBC) in the PADA-1 trial
Frenel, J-S., Dalenc, F., Pistilli, B., de La Motte Rouge, T., Levy, C., Mouret-Reynier, M-A., Hardy-Bessard, A-C., Bonichon-Lamichhane, N., Greilsamer, C., Delecroix, V., Nguyen, S., Berger, F., Everhard, S., Lemonnier, J., Loirat, D., Callens, C., Pradines, A., Bachelot, T., Delaloge, S., Bidard, F.C.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
LBA21 Neoadjuvant mFOLFIRINOX and preoperative chemoradiation (CRT) versus preoperative CRT in patients with T3-4 rectal cancer: Surgical and quality of life results of PRODIGE 23 phase III trial
Borg, C., Rullier, E., Marchal, F., Etienne, P-L., Rio, E., Francois, E., Mesgouez-Nebout, N., Vendrely, V., Artignan, X., Bouche, O., Gargot, D., Boige, V., Bonichon-Lamichhane, N., Louvet, C., Morand, C., de la Fouchardiere, C., Juzyna, B., Mollevi, C., Castan, F., Conroy, T.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
Randomised, open-label, multicentric phase III trial to evaluate the safety and efficacy of palbociclib in combination with endocrine therapy, guided by ESR1 mutation monitoring in oestrogen receptor-positive, HER2-negative metastatic breast cancer patients: study design of PADA-1
Berger, Frédérique, Marce, Margaux, Hardy-Bessard, Anne-Claire, Bachelot, Thomas, Bièche, Ivan, Pradines, Anne, De La Motte Rouge, Thibault, Canon, Jean-Luc, André, Fabrice, Clatot, Florian, Lemonnier, Jérôme, Marques, Sandrine, Bidard, François-Clement, Achille, M, Alleaume, C, Ammarguellat, H, Arsene, O, Bachelot, T, Barthelemy, P, Barthier, S, Bernard-Marty, C, Bonichon-Lamichhane, N, Bonnin, N, Bouaita, R, Boudrant, A, Brunel, V-A, Chakiba, C, Cheneau, C, Clatot, F, Dalenc, F, De Gramont, A, de La Motte Rouge, T, Deiana, L, Del Piano, F, Delbaldo, C, Delecroix, V, Derbel, O, Desclos, H, D'Hondt, V, Dohollou, N, Dubot, C, Escande, A, Ferrero, J-M, Foa, C, Frenel, J-S, Gardner, M, Garnier Tixidre, C, Genet, D, Gisserot, O, Gozy, M, Greilsamer, C, Grenier, J, Guinet, F, Hardy-Bessard, A-C, Jacquin, J-P, Joly, L, Lachaier, E, Ladoire, S, Laurenty, A-P, Le Scodan, R, Leduc, N, Levache, C, Lorchel, F, Lortholary, A, Lucas, B, Marques, N, Marti, A, Melis, A, Mille, D, Mollon, D, Moreau, L, Moullet, I, Mouret-Reynier, M-A, Najem, A, Nguyen, S, Orfeuvre, H, Paitel, J-F, Petit, T, Pistilli, B, Plaza, J, Riedl, C, Sabatier, R, Soulie, P, Spaeth, D, Stefani, L, Teixeira, L, Trouboul, F, Valmar, C, Vegas, H, Venat-Bouvet, L, Zannetti, A, Bidard, FC, Delaloge, S, Bièche, I, Clatot, Florian, Canon, JL, André, F, Arnould, L, Berger, F, Marques, S
Published in BMJ open (03.03.2022)
Published in BMJ open (03.03.2022)
Get full text
Journal Article
1037P - Post-hoc analysis of the nintedanib exposure-response relationships in the CHIVA trial in advanced ovarian cancer: A GINECO study
Haviari, S., Blanchet, B., Colomban, O., Venat-Bouvet, L., Dohollou, N., Floquet, A., Louvet, C., Lotz, J.-P., Lacourtoisie, S Abadie, Favier, L., Fabbro, M., Bonichon-Lamichhane, N., Kurtz, J.E., Follana, P., Leheurteur, M., Del Piano, F., Alliot, C.R., Alexandre, J., You, B., Tod, M.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1037PPost-hoc analysis of the nintedanib exposure-response relationships in the CHIVA trial in advanced ovarian cancer: A GINECO study
Haviari, S, Blanchet, B, Colomban, O, Venat-Bouvet, L, Dohollou, N, Floquet, A, Louvet, C, Lotz, J-P, Lacourtoisie, S Abadie, Favier, L, Fabbro, M, Bonichon-Lamichhane, N, Kurtz, J E, Follana, P, Leheurteur, M, Del Piano, F, Alliot, C R, Alexandre, J, You, B, Tod, M
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Post-hoc analysis of the nintedanib exposure-response relationships in the CHIVA trial in advanced ovarian cancer: A GINECO study
Haviari, S., Blanchet, B., Colomban, O., Venat-Bouvet, L., Dohollou, N., Floquet, A., Louvet, C., Lotz, J.-P., Lacourtoisie, S Abadie, Favier, L., Fabbro, M., Bonichon-Lamichhane, N., Kurtz, J.E., Follana, P., Leheurteur, M., Del Piano, F., Alliot, C.R., Alexandre, J., You, B., Tod, M.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
OC-0284: First results of the French cohort ANABASE : treatment and outcome in non-metastatic anal cancer
Vendrely, V., Lemanski, C., François, E., Barbier, E., Baba Hamed, N., Bonichon-Lamichhane, N., De La Rochefordière, A., Bouché, O., Tougeron, D., Diaz, O., Pommier, P., Ronchin, P., Saliou, M., Cretin, J., Lepage, C., Quéro, L.
Published in Radiotherapy and oncology (01.04.2018)
Published in Radiotherapy and oncology (01.04.2018)
Get full text
Journal Article
Outcomes of the combination trabectedin and pegylated liposomal doxorubicin (T-PLD) in recurrent platinum-sensitive ovarian cancer (OC): a GINECO cohort study
Selle, F., Heudel, P-E., Tazi, Y., Pozet, A., Hardy-Bessard, A-C., Meunier, J., Gladieff, L., Lotz, J-P., Provansal, M., Augereau, P., Frenel, J-S., Bonichon-Lamichhane, N., Orfeuvre, H., Pommeret, F., Torres-Macque, M., Kalbacher, E., Roemer-Becuwe, C.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
59P Expression of CD47 a potent ‘don’t eat me signal' in ovarian cancer (OC): Correlation with other immune features and evolution under neoadjuvant chemotherapy (NACT), a GINEGEPS study
Chardin, L., Yaniz Galende, E., Genestie, C., Le Formal, A., Schneider, C., Jeanne, A., Venat-Bouvet, L., Louvet, C., Favier, L., Lortholary, A., Berton-Rigaud, D., Dohollou, N., Desauw, C., Fabbro, M., Malaurie, E., Dubot, C., Kurtz, J.E., Bonichon Lamichhane, N., Dedieu, S., Leary, A.
Published in ESMO open (01.02.2023)
Published in ESMO open (01.02.2023)
Get full text
Journal Article
Robustesse du guidage surfacique en comparaison avec le spiromètre dans la mise en place du blocage respiratoire pour le traitement du cancer du sein
Messina, C., Guibert, A.-L., Martin, G., Chauvet, V., Bonichon-Lamichhane, N., Debelleix, C., Régnault de la Mothe, P., Taupiac, J.P., Mineur, H.
Published in Cancer radiothérapie (01.10.2020)
Published in Cancer radiothérapie (01.10.2020)
Get full text
Journal Article
Sites de récidives du cancer du canal anal après chimioradiothérapie avec modulation d’intensité : analyse rétrospective multicentrique
Amestoy, F., Antoine, M., Henriques, B., Lipinski, F., Genebes, C., Blouet, A., Celerier, D., Regnault de la Mothe, P., Debelleix, C., Petit, A., Laharie-Mineur, H., Bonichon-Lamichhane, N., Vendrely, V.
Published in Cancer radiothérapie (01.10.2018)
Published in Cancer radiothérapie (01.10.2018)
Get full text
Journal Article
Traitement du cancer du canal anal : premiers résultats de la cohorte nationale Anabase
Vendrely, V., Lemanski, C., Baba-Hamed, N., Barbier, E., Bénézery, K., de La Rochefordière, A., Guibert, P., Bonichon-Lamichhane, N., Pommier, P., Créhange, G., Colliaux, J., Gnep, K., Ronchin, P., Saliou, M., Diaz, O., Lepage, C., Quéro, L.
Published in Cancer radiothérapie (01.10.2018)
Published in Cancer radiothérapie (01.10.2018)
Get full text
Journal Article